United States

Health News


Roche's Alecensa latest beneficiary of faster China drug approvals 2:25am EDT

ZURICH Roche's Alecensa lung cancer medicine became the latest beneficiary of China's efforts to speed up approvals in the world's second-biggest drug market, which is gaining importance for global pharmaceuticals companies' growth plans.

More Headlines


China think tank slammed for 'procreation fund' idea

BEIJING A proposal by two Chinese researchers to force couples with fewer than two children to pay into a "procreation fund" backfired on Friday, with critics calling it a "thoughtless" and "absurd" way to battle the problem of an ageing population.

Aug 17 2018

World's top pork firm shuts China slaughterhouse in race to contain deadly swine fever

BEIJING China has ordered the world's top pork producer, WH Group Ltd, to shut a major slaughterhouse as authorities race to stop the spread of deadly African swine fever (ASF) after a second outbreak in the planet's biggest hog herd in two weeks.

China Aug 17 2018

Many people take drugs that interfere with their blood pressure pills

(Reuters Health) - People who take pills to lower their blood pressure often take other drugs that reduce the pills' effectiveness, a recent study suggests.

Aug 17 2018

Dementia patients may benefit from music therapy

(Reuters Health) - Music therapy may improve depression and anxiety in dementia patients, a new analysis suggests.

Aug 17 2018